Free Trial

Tpg Gp A LLC Acquires 3,186 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background

Key Points

  • Tpg Gp A LLC increased its stake in UnitedHealth Group by 2.2%, acquiring an additional 3,186 shares, now holding a total of 144,948 shares valued at approximately $75.9 million.
  • Insider transactions included the sale of 589 shares by CEO Patrick Hugh Conway, representing a 5.36% decrease in his ownership.
  • Analyst ratings for UnitedHealth Group show a mix of opinions, with 15 Buy, 6 Hold, and 3 Sell ratings, alongside a reduced target price from $353 to $317 by Piper Sandler.
  • MarketBeat previews top five stocks to own in October.

Tpg Gp A LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 144,948 shares of the healthcare conglomerate's stock after buying an additional 3,186 shares during the period. UnitedHealth Group makes up approximately 1.5% of Tpg Gp A LLC's holdings, making the stock its 13th biggest position. Tpg Gp A LLC's holdings in UnitedHealth Group were worth $75,917,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Bayforest Capital Ltd raised its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the first quarter valued at about $42,000. Copia Wealth Management bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $42,000. Finally, O Brien Wealth Partners LLC boosted its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.28% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Wall Street Zen downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Piper Sandler reduced their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Fifteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $353.00.

Check Out Our Latest Stock Analysis on UNH

UnitedHealth Group Trading Up 2.5%

Shares of UNH opened at $309.77 on Friday. The stock has a 50 day simple moving average of $288.16 and a 200-day simple moving average of $380.68. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market cap of $280.55 billion, a PE ratio of 13.42, a PEG ratio of 2.00 and a beta of 0.43. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the business posted $6.80 earnings per share. The firm's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines